Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer

Affiliations

Comment

Tim Thomas. Nat Rev Urol. 2023 Apr.

. 2023 Apr;20(4):197.

doi: 10.1038/s41585-023-00753-y.

No abstract available

Comment on

Small Suspicious Lymph Nodes Detected on Ultrahigh-field Magnetic Resonance Imaging (MRI) in Patients with Prostate Cancer with High Risk of Nodal Metastases: The First In-patient Study on Ultrasmall Superparamagnetic Iron Oxide-enhanced 7T MRI.
Fortuin A, van Asten J, Veltien A, Philips B, Hambrock T, Johst S, Orzada S, Hadaschik B, Quick H, Barentsz J, Maas M, Scheenen T. Fortuin A, et al. Eur Urol. 2023 Apr;83(4):375-377. doi: 10.1016/j.eururo.2023.01.002. Epub 2023 Feb 2. Eur Urol. 2023. PMID: 36739192 No abstract available.
Sentinel Node Procedure to Select Clinically Localized Prostate Cancer Patients with Occult Nodal Metastases for Whole Pelvis Radiotherapy.
de Barros HA, Duin JJ, Mulder D, van der Noort V, Noordzij MA, Wit EMK, Pos FJ, Vogel WV, Schaake EE, van Leeuwen FWB, van Leeuwen PJ, Grivas N, van der Poel HG. de Barros HA, et al. Eur Urol Open Sci. 2023 Jan 30;49:80-89. doi: 10.1016/j.euros.2022.12.011. eCollection 2023 Mar. Eur Urol Open Sci. 2023. PMID: 36874598 Free PMC article.

1. de Barros, H. A. et al. Sentinel node procedure to select clinically localized prostate cancer patients with occult nodal metastases for whole pelvis radiotherapy. Eur. Urol. Open Sci. 49, 80–89 (2023) - DOI - PubMed - PMC
1. Fortuin, A. et al. Small suspicious lymph nodes detected on ultrahigh-field magnetic resonance imaging (MRI) in patients with prostate cancer with high risk of nodal metastases: the first in-patient study on ultrasmall superparamagnetic iron oxide-enhanced 7T MRI. Eur. Urol. https://doi.org/10.1016/j.eururo.2023.01.002 (2023) - DOI - PubMed